HK1060567A1 - Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament. - Google Patents
Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament.Info
- Publication number
- HK1060567A1 HK1060567A1 HK04103583A HK04103583A HK1060567A1 HK 1060567 A1 HK1060567 A1 HK 1060567A1 HK 04103583 A HK04103583 A HK 04103583A HK 04103583 A HK04103583 A HK 04103583A HK 1060567 A1 HK1060567 A1 HK 1060567A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- medicament
- producing
- production
- same
- crystalline monohydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Crystalline monohydrate (I) of tiotropium bromide ((1alpha,2beta,4beta,5alpha,7beta)-7-(2-hydroxy-2,2-di(2-thienyl)acetoxy)-9,9-dimethyl-3-oxa-9-azonia-tricyclo(3.3.1.02.4)nonane bromide) is new. An Independent claim is also included for the preparation of (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10050621 | 2000-10-12 | ||
PCT/EP2001/011225 WO2002030928A1 (en) | 2000-10-12 | 2001-09-28 | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1060567A1 true HK1060567A1 (en) | 2004-08-13 |
Family
ID=7659568
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK04103583A HK1060567A1 (en) | 2000-10-12 | 2004-05-20 | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament. |
HK06106478.2A HK1086557A1 (en) | 2000-10-12 | 2006-06-07 | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06106478.2A HK1086557A1 (en) | 2000-10-12 | 2006-06-07 | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
Country Status (47)
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1401445T3 (en) * | 2001-06-22 | 2006-11-27 | Boehringer Ingelheim Pharma | Crystalline anticholinergic, method of preparing it and using it to prepare a drug |
US6608055B2 (en) | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
DE10212264A1 (en) | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Crystalline micronisate, process for its preparation and its use for the manufacture of a medicament |
DE10214263A1 (en) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA suspension formulations containing an anticholinergic |
US7244415B2 (en) | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
US7311894B2 (en) | 2002-03-28 | 2007-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations containing an anticholinergic |
US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
DE10317461A1 (en) | 2003-04-16 | 2004-10-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt |
SI1682542T1 (en) * | 2003-11-03 | 2010-04-30 | Boehringer Ingelheim Int | Novel crystalline anhydride with anticholinergic effect |
DK2083007T3 (en) * | 2003-11-03 | 2013-07-29 | Boehringer Ingelheim Int | Tiotropium salts, processes for their preparation, and drug formulations containing them |
US7968717B2 (en) | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
DK1682541T3 (en) * | 2003-11-03 | 2010-06-28 | Boehringer Ingelheim Int | Process for the preparation of tiotropium salts |
DE102004016179A1 (en) * | 2004-03-30 | 2005-10-20 | Boehringer Ingelheim Pharma | Compounds for the treatment of proliferative processes |
AU2005235419B2 (en) | 2004-04-22 | 2010-11-04 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations containing benzoxazine for treating respiratory diseases |
DE102004024454A1 (en) | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals |
US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
ES2322148T3 (en) | 2004-08-11 | 2009-06-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | MEDICINES CONTAINING ANTI-POLINERGIC FOR TREATMENT IN URINARY ROADS. |
US20060079544A1 (en) * | 2004-08-13 | 2006-04-13 | Boehringer Ingelheim International Gmbh | Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic |
DE102004048389A1 (en) | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Modification of surfaces of lactose as adjuvant for use with powder inhalants |
BRPI0517282A (en) * | 2004-10-21 | 2008-10-07 | Boehringer Ingelheim Int | inhaler blister |
JP2008532973A (en) * | 2005-03-09 | 2008-08-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Novel pharmaceutical composition based on anticholinergic and PDE5-inhibitor |
CA2605688A1 (en) | 2005-04-28 | 2006-11-02 | Boehringer Ingelheim International Gmbh | Compounds for treating inflammatory diseases |
AU2006243239A1 (en) * | 2005-05-02 | 2006-11-09 | Boehringer Ingelheim International Gmbh | Crystalline forms of tiotropium bromide |
SI1881980T1 (en) | 2005-05-02 | 2012-12-31 | Boehringer Ingelheim International Gmbh | Novel crystalline forms of tiotropium bromide |
WO2006134021A2 (en) * | 2005-06-15 | 2006-12-21 | Boehringer Ingelheim International Gmbh | Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof |
DE102005030733A1 (en) | 2005-07-01 | 2007-01-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient |
RU2422144C2 (en) * | 2005-08-06 | 2011-06-27 | Бёрингер Ингельхайм Интернациональ Гмбх | Application of tiotropium salts for treatment of severe forms of persistent asthma |
WO2007020227A1 (en) | 2005-08-15 | 2007-02-22 | Boehringer Ingelheim International Gmbh | Method for producing betamimetics |
US20070086957A1 (en) | 2005-10-10 | 2007-04-19 | Thierry Bouyssou | Combination of medicaments for the treatment of respiratory diseases |
US7423146B2 (en) | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
DE102005059602A1 (en) * | 2005-12-14 | 2007-06-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Micronization process |
ES2384486T3 (en) | 2005-12-19 | 2012-07-05 | Sicor, Inc. | New form of tiotropium bromide and procedure for its preparation |
MX2007009987A (en) * | 2005-12-19 | 2007-10-02 | Sicor Inc | Pure and stable tiotropium bromide. |
MY146362A (en) * | 2006-01-04 | 2012-08-15 | Boehringer Ingelheim Int | Use of tiotropium salts in the treatment of moderate persistent asthma |
EP1847543A1 (en) | 2006-04-19 | 2007-10-24 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dihydrothienopyrimidines for the treatment of inflammatory diseases |
EP1874781B9 (en) | 2006-04-19 | 2010-09-08 | Boehringer Ingelheim International GmbH | Dihydrothienopyrimidines for the treatment of inflammatory diseases |
US20080051582A1 (en) | 2006-07-10 | 2008-02-28 | Sicor Inc. | Process for the preparation of tiotropium bromide |
JP2010500318A (en) | 2006-08-07 | 2010-01-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Pharmaceutical composition for the treatment of respiratory diseases |
PE20080610A1 (en) | 2006-08-22 | 2008-07-15 | Boehringer Ingelheim Int | NEW ENANTHOMERICALLY PURE BETA-AGONISTS, PROCEDURES FOR THEIR PREPARATION AND USE AS MEDICINES |
EP1923393A1 (en) * | 2006-11-17 | 2008-05-21 | Boehringer Ingelheim Pharma GmbH & Co. KG | Crystalline form of tiotropium bromide and urea |
EP1925295A1 (en) | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stable powder formulation containing a new antichinolinergic agent |
GB0716026D0 (en) * | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
NZ585346A (en) | 2007-10-19 | 2011-09-30 | Boehringer Ingelheim Int | Substituted piperidino-dihydrothienopyrimidines |
EP2093219A1 (en) | 2008-02-22 | 2009-08-26 | Boehringer Ingelheim International Gmbh | Crystalline enantiomer free salt form of a betamimetic and its use as medicine |
WO2010011813A1 (en) * | 2008-07-23 | 2010-01-28 | Alkermes, Inc. | Complex of trospium and pharmaceutical compositions thereof |
PE20120061A1 (en) | 2008-12-19 | 2012-02-19 | Boehringer Ingelheim Int | PYRIMIDINE DERIVATIVES AS ANTAGONISTS OF THE CCR2 RECEPTOR |
EP2201934A1 (en) | 2008-12-23 | 2010-06-30 | CHIESI FARMACEUTICI S.p.A. | Tiotropium aerosol formulation products with improved chemical stability |
WO2010101538A2 (en) | 2009-03-06 | 2010-09-10 | Bilgic Mahmut | New crystal forms |
IN2012DN00968A (en) | 2009-08-07 | 2015-04-10 | Generics Uk Ltd | |
WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
WO2011073155A1 (en) | 2009-12-17 | 2011-06-23 | Boehringer Ingelheim International Gmbh | Novel antagonists for ccr2 and uses thereof |
EA024397B1 (en) | 2009-12-17 | 2016-09-30 | Сентрекшн Терапьютикс Корпорейшн | New ccr2 receptor antagonists and uses thereof |
EA201201052A1 (en) | 2010-01-29 | 2013-02-28 | Бёрингер Ингельхайм Интернациональ Гмбх | SUBSTITUTED NAFTYRIDINE AND THEIR APPLICATION AS KINASE SYK INHIBITORS |
WO2011141477A1 (en) | 2010-05-12 | 2011-11-17 | Boehringer Ingelheim International Gmbh | New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments |
JP2013526507A (en) | 2010-05-12 | 2013-06-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | NOVEL CCR2 RECEPTOR ANTAGONIST, PROCESS FOR PRODUCING THE SAME AND USE THEREOF AS DRUG |
JP5647339B2 (en) | 2010-05-17 | 2014-12-24 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | CCR2 antagonists and uses thereof |
WO2011147772A1 (en) | 2010-05-25 | 2011-12-01 | Boehringer Ingelheim International Gmbh | Ccr2 receptor antagonists |
US8962656B2 (en) | 2010-06-01 | 2015-02-24 | Boehringer Ingelheim International Gmbh | CCR2 antagonists |
EP2668177B1 (en) | 2011-01-28 | 2014-10-22 | Boehringer Ingelheim International GmbH | Substituted pyridinyl-pyrimidines and their use as medicaments |
TR201102068A2 (en) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Crystalline substances containing tiotropium bromide |
JP5786257B2 (en) | 2011-06-16 | 2015-09-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Novel selective CCR2 antagonist |
JP5786258B2 (en) | 2011-07-15 | 2015-09-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Novel and selective CCR2 antagonist |
CN103827090B (en) | 2011-07-26 | 2016-04-20 | 勃林格殷格翰国际有限公司 | The quinoline replaced and the purposes as medicine thereof |
US20130059866A1 (en) | 2011-08-24 | 2013-03-07 | Boehringer Ingelheim International Gmbh | Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
CZ304368B6 (en) * | 2011-11-28 | 2014-04-02 | Zentiva, K.S. | Tiotropium bromide mixed solvate and process for preparing thereof |
GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
US9096579B2 (en) | 2012-04-20 | 2015-08-04 | Boehringer Ingelheim International Gmbh | Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments |
RS55919B1 (en) | 2012-11-05 | 2017-09-29 | Zentiva As | Stabilization of tiotropium solvates |
EP2913332A1 (en) * | 2014-02-27 | 2015-09-02 | Euticals S.P.A. | Crystalline form of tiotropium bromide with lactose |
DK3119772T3 (en) | 2014-03-19 | 2019-08-26 | Boehringer Ingelheim Int | HETEROARYL SICK INHIBITORS |
US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
RU2567539C1 (en) * | 2015-02-04 | 2015-11-10 | Индивидуальный предприниматель Михайлов Олег Ростиславович | CRYSTALLINE γ-MODIFICATION (1α,2β,4β,5α,7β)-7-[(HYDROXYDI-2-THIENYLACETYL)OXY]-9,9-DIMETHYL-3-OXA-9-AZONIATRICYCLO[3,3,1,02,4]NONANE BROMIDE MONOHYDRATE, METHOD OF THEREOF OBTAINING AND THEREOF-BASED PHARMACEUTICAL COMPOSITION |
WO2017138896A1 (en) | 2016-02-11 | 2017-08-17 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti | Crystalline form of tiotropium bromide anhydrate |
WO2018084817A2 (en) * | 2016-11-04 | 2018-05-11 | Si̇ma Patent Ve Li̇sanslama Hi̇zmetleri̇ Ltd. Şti̇ | A new form of active agent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3931041C2 (en) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them |
SK280911B6 (en) * | 1992-12-09 | 2000-09-12 | Boehringer Ingelheim Pharmaceuticals, Inc. | Pharmaceutical composition |
DE19834506A1 (en) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Transmucosal therapeutic system for the use of sildenafil |
EP1102579B1 (en) * | 1998-08-04 | 2003-03-19 | Jago Research Ag | Medicinal aerosol formulations |
-
2001
- 2001-09-28 DK DK01983510T patent/DK1326862T3/en active
- 2001-09-28 UA UA2003054185A patent/UA74215C2/en unknown
- 2001-09-28 EA EA200300457A patent/EA004381B1/en not_active IP Right Cessation
- 2001-09-28 EE EEP200300171A patent/EE04567B1/en unknown
- 2001-09-28 DE DE50103666T patent/DE50103666D1/en not_active Expired - Lifetime
- 2001-09-28 BR BR0114584-3A patent/BR0114584A/en active Pending
- 2001-09-28 CN CNB018171435A patent/CN1221549C/en not_active Ceased
- 2001-09-28 AP APAP/P/2003/002775A patent/AP1572A/en active Active
- 2001-09-28 MX MXPA03003221A patent/MXPA03003221A/en active IP Right Grant
- 2001-09-28 ME MEP-2008-400A patent/ME00243B/en unknown
- 2001-09-28 ME MEP-400/08A patent/MEP40008A/en unknown
- 2001-09-28 AU AU1499602A patent/AU1499602A/en active Pending
- 2001-09-28 CA CA002425539A patent/CA2425539C/en not_active Expired - Lifetime
- 2001-09-28 RS YU27303A patent/RS50218B/en unknown
- 2001-09-28 NZ NZ525733A patent/NZ525733A/en not_active IP Right Cessation
- 2001-09-28 EP EP04016877A patent/EP1468998A1/en not_active Withdrawn
- 2001-09-28 OA OA1200300107A patent/OA12403A/en unknown
- 2001-09-28 IL IL15533501A patent/IL155335A0/en active IP Right Grant
- 2001-09-28 HU HU0301022A patent/HU226830B1/en unknown
- 2001-09-28 WO PCT/EP2001/011225 patent/WO2002030928A1/en active IP Right Grant
- 2001-09-28 CZ CZ20031025A patent/CZ301841B6/en not_active IP Right Cessation
- 2001-09-28 PL PL366041A patent/PL207870B1/en unknown
- 2001-09-28 TR TR2004/02579T patent/TR200402579T4/en unknown
- 2001-09-28 AU AU2002214996A patent/AU2002214996B2/en not_active Expired
- 2001-09-28 KR KR1020037005083A patent/KR100823860B1/en active IP Right Grant
- 2001-09-28 CN CNB2005100977370A patent/CN100519558C/en not_active Ceased
- 2001-09-28 GE GE5214A patent/GEP20063905B/en unknown
- 2001-09-28 SI SI200130219T patent/SI1326862T1/en unknown
- 2001-09-28 ES ES01983510T patent/ES2228965T3/en not_active Expired - Lifetime
- 2001-09-28 JP JP2002534314A patent/JP3764422B2/en not_active Expired - Lifetime
- 2001-09-28 EP EP01983510A patent/EP1326862B1/en not_active Expired - Lifetime
- 2001-09-28 DZ DZ013478A patent/DZ3478A1/en active
- 2001-09-28 AT AT01983510T patent/ATE276253T1/en active
- 2001-09-28 PT PT01983510T patent/PT1326862E/en unknown
- 2001-09-28 SK SK436-2003A patent/SK287009B6/en not_active IP Right Cessation
- 2001-10-02 SA SA01220412A patent/SA01220412B1/en unknown
- 2001-10-09 TW TW090124963A patent/TW589313B/en active
- 2001-10-09 EG EG20011058A patent/EG24142A/en active
- 2001-10-10 UY UY26962A patent/UY26962A1/en not_active Application Discontinuation
- 2001-10-10 MY MYPI20014705A patent/MY126931A/en unknown
- 2001-10-10 PE PE2001001000A patent/PE20020422A1/en active IP Right Grant
- 2001-10-12 AR ARP010104782A patent/AR034389A1/en active Pending
-
2003
- 2003-03-26 CR CR6938A patent/CR6938A/en unknown
- 2003-03-28 BG BG107687A patent/BG66161B1/en active Active
- 2003-03-31 ZA ZA200302500A patent/ZA200302500B/en unknown
- 2003-04-07 EC EC2003004540A patent/ECSP034540A/en unknown
- 2003-04-08 MA MA27102A patent/MA25842A1/en unknown
- 2003-04-09 IS IS6772A patent/IS2339B/en unknown
- 2003-04-10 HR HR20030276A patent/HRP20030276B1/en not_active IP Right Cessation
- 2003-04-10 IL IL155335A patent/IL155335A/en unknown
- 2003-04-11 NO NO20031694A patent/NO328465B1/en not_active IP Right Cessation
-
2004
- 2004-05-20 HK HK04103583A patent/HK1060567A1/en not_active IP Right Cessation
-
2006
- 2006-06-07 HK HK06106478.2A patent/HK1086557A1/en not_active IP Right Cessation
-
2008
- 2008-09-19 AR ARP080104109A patent/AR068527A2/en unknown
-
2013
- 2013-07-11 UY UY34901A patent/UY34901A/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1086557A1 (en) | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament | |
RS57551B1 (en) | Micronized crystalline tiotropium bromide | |
HUP0400333A2 (en) | Crystalline anticholinergic, method for its production, and use thereof in the production of pharmaceutical composition | |
YU50903A (en) | Method for producing the anticholinergic agent tiotropium bromide | |
SG158731A1 (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
AU2002214996A1 (en) | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament | |
EE05287B1 (en) | The so-called clopentanoindoles, their use in the manufacture of a medicament and the pharmaceutical composition containing them | |
WO2002072095A3 (en) | Tiotropium salts for treating inflammatory diseases | |
PT1474415E (en) | 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases | |
UA3713U (en) | METHOD OF CORRECTION OF IMMUNOLOGICAL STATUS DISORDERS IN CHILDREN | |
ITRM20020257A0 (en) | USE OF THE STABLE FORM OF PROSTACYCLIN I2 (ILOPROST) IN THE TREATMENT OF NON-EXUDATIVE SENILE MACULAR GENERATION. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170928 |